John M M. Pagel, N/A

Chief of Hematologic Malignancies, Center for Blood Disorders and Stem Cell Transplantation
Loxo@Lilly, Indianapolis, IN, USA

NA

Poster(s):

• 2012 - Matching-Adjusted Indirect Comparison of Pirtobrutinib vs Venetoclax Continuous Monotherapy in Patients with Relapsed/Refractory CLL Previously Treated with a Covalent BTK Inhibitor